These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15367478)

  • 1. Working together: a qualitative study of effective group formation amongst GPs during a cost-driven prescribing initiative.
    Walker J; Mathers N
    Fam Pract; 2004 Oct; 21(5):552-8. PubMed ID: 15367478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motivating general practitioners to change their prescribing: the incentive of working together.
    Ashworth M; Armstrong D; Colwill S; Cohen A; Balazs J
    J Clin Pharm Ther; 2000 Apr; 25(2):119-24. PubMed ID: 10849189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
    Prosser H; Walley T
    Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General practitioners' views on using a prescribing substitution application (ScriptSwitch(®)).
    Hire C; Rushforth B
    Inform Prim Care; 2013; 21(1):1-11. PubMed ID: 24629649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study.
    Watkins C; Timm A; Gooberman-Hill R; Harvey I; Haines A; Donovan J
    Fam Pract; 2004 Dec; 21(6):661-9. PubMed ID: 15528289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of factors associated with cost and variation in prescribing among GPs.
    Carthy P; Harvey I; Brawn R; Watkins C
    Fam Pract; 2000 Feb; 17(1):36-41. PubMed ID: 10673486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prescribing of specialist medicines: what factors influence GPs' decision making?
    Crowe S; Tully MP; Cantrill JA
    Fam Pract; 2009 Aug; 26(4):301-8. PubMed ID: 19505976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects on GP prescribing of joining a commissioning group.
    Ashworth M; Armstrong D; Lloyd D; Colwill S
    J Clin Pharm Ther; 2002 Jun; 27(3):221-8. PubMed ID: 12081637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of a general practice group intervention on prescribing costs and patterns.
    Walker J; Mathers N
    Br J Gen Pract; 2002 Mar; 52(476):181-6. PubMed ID: 12030659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New medicines in primary care: a review of influences on general practitioner prescribing.
    Mason A
    J Clin Pharm Ther; 2008 Feb; 33(1):1-10. PubMed ID: 18211610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in understanding the drug-prescribing process: a qualitative study among Swedish GPs.
    Rahmner PB; Gustafsson LL; Larsson J; Rosenqvist U; Tomson G; Holmström I
    Fam Pract; 2009 Apr; 26(2):121-7. PubMed ID: 19103613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing junior doctors' prescribing practices through collaborative practice: Sustaining and transforming the practice of communities.
    Noble C; Brazil V; Teasdale T; Forbes M; Billett S
    J Interprof Care; 2017 Mar; 31(2):263-272. PubMed ID: 28140691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand.
    Hatah E; Braund R; Duffull SB; Tordoff J
    J Prim Health Care; 2013 Sep; 5(3):223-33. PubMed ID: 23998173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared care: a qualitative study of GPs' and hospital doctors' views on prescribing specialist medicines.
    Horne R; Mailey E; Frost S; Lea R
    Br J Gen Pract; 2001 Mar; 51(464):187-93. PubMed ID: 11255899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost and cost-effectiveness of PPIs--GP perspectives and responses to a prescribing dilemma and their implications for the development of patient-centred healthcare.
    Pollock K; Grime J
    Eur J Gen Pract; 2003 Dec; 9(4):126-33, 140. PubMed ID: 14733400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of the impact of primary care organizations on GP prescribing: the iron fist in the velvet glove?
    Prosser H; Walley T
    J Health Organ Manag; 2007; 21(1):5-26. PubMed ID: 17455809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs.
    Jacoby A; Smith M; Eccles M
    Br J Gen Pract; 2003 Feb; 53(487):120-5. PubMed ID: 12817357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the impact of NICE guidance on GP prescribing.
    Wathen B; Dean T
    Br J Gen Pract; 2004 Feb; 54(499):103-7. PubMed ID: 14965388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative study exploring how GPs decide to prescribe antidepressants.
    Hyde J; Calnan M; Prior L; Lewis G; Kessler D; Sharp D
    Br J Gen Pract; 2005 Oct; 55(519):755-62. PubMed ID: 16212850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing GPs' choice between drugs in a therapeutic drug group. A qualitative study.
    Buusman A; Andersen M; Merrild C; Elverdam B
    Scand J Prim Health Care; 2007 Dec; 25(4):208-13. PubMed ID: 18041657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.